Tag: immune-mediated diseases

Microbiome company Vedanta Biosciences raises $68m in Series D

pallavi123- July 21, 2021

Vedanta Biosciences, a clinical-stage microbiome company founded by PureTech Health, has raised $68 million in a Series D financing round led by affiliates of Magnetar ... Read More

Sanofi to acquire UK-based biopharma company Kymab in $1.4bn worth deal

pharmanewsdaily- January 12, 2021

Sanofi acquisition of Kymab : French pharma giant Sanofi has signed a deal worth up to $1.45 billion to acquire Kymab, a UK-based clinical-stage biopharma ... Read More

Sanofi to acquire US biopharma company Principia Biopharma for $3.7bn

pharmanewsdaily- August 17, 2020

Sanofi acquisition of Principia Biopharma : French pharma giant Sanofi has signed an all-cash deal worth $3.68 billion to acquire Principia Biopharma, a late-stage California-based ... Read More